1. Arginine Methylation of hnRNPK Inhibits the DDX3-hnRNPK Interaction to Play an Anti-Apoptosis Role in Osteosarcoma Cells
   Chiao-Che Chen et al, 2021, International Journal of Molecular Sciences CrossRef
2. Prostate cancer and therapeutic challenges
   Yousef MohammedRabaa Hawsawi et al, 2020, Journal of Biological Research-Thessaloniki CrossRef
3. Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma
   Jiawei Zhou et al, 2021, Aging CrossRef
4. Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
   Seta Derderian et al, 2023, The Journal of Pathology: Clinical Research CrossRef
5. O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
   Chatchai Phoomak et al, 2019, Molecular Oncology CrossRef
6. A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
   Philipp Y Maximov et al, 2018, Endocrine-Related Cancer CrossRef
7. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression
   Paola Barboro et al, 2014, Cancer Letters CrossRef
8. Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer
   Roberto Benelli et al, 2019, International Journal of Molecular Sciences CrossRef
9. RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways
   Xiao-Chen Xu et al, 2021, Journal of Genetics and Genomics CrossRef
10. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
    Antonella Brizzolara et al, 2017, Cancer Letters CrossRef
11. Prognostic relevance of androgen receptor expression in renal cell carcinomas
    Sebastian Foersch et al, 2017, Oncotarget CrossRef
12. HnRNPM is a potential mediator of YY1 which promotes EMT in prostate cancer cells
    Tong Yang et al, 2019, The Prostate CrossRef
13. Knockdown of hnRNPK leads to increased DNA damage after irradiation and reduces survival of tumor cells
    Nadine Wiesmann et al, 2017, Carcinogenesis CrossRef
14. Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
    Nicoletta Ferrari et al, 2017, Cell Communication and Signaling CrossRef
15. The emerging roles of hnRNPK
    Ziyi Wang et al, 2020, Journal of Cellular Physiology CrossRef
16. Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer
    Harley Robinson et al, 2021, Clinical and Translational Medicine CrossRef
17. Gene’s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study
    Matteo Bauckneht et al, 2023, Journal of Translational Medicine CrossRef
18. Stromal Androgen Receptor in Prostate Cancer Development and Progression
    Damien Leach et al, 2017, Cancers CrossRef
19. Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer
    Ruirui Yang et al, 2016, Oncology Reports CrossRef
20. Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP‐1: New player in tumor progression
    Paola Barboro et al, 2015, International Journal of Cancer CrossRef
21. A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
    Matteo Capaia et al, 2018, International Journal of Molecular Sciences CrossRef
22. Role of heterogeneous nuclear ribonucleoprotein K in tumor development
    Yuting Chen et al, 2019, Journal of Cellular Biochemistry CrossRef